ag 1879 has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies
3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lou, L | 1 |
| Yu, Z | 1 |
| Wang, Y | 1 |
| Wang, S | 1 |
| Zhao, Y | 1 |
| Tabariès, S | 1 |
| Annis, MG | 1 |
| Hsu, BE | 1 |
| Tam, CE | 1 |
| Savage, P | 1 |
| Park, M | 1 |
| Siegel, PM | 1 |
2 other studies available for ag 1879 and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
c-Src inhibitor selectively inhibits triple-negative breast cancer overexpressed Vimentin in vitro and in vivo.
Topics: Animals; Cell Line, Tumor; CSK Tyrosine-Protein Kinase; Epithelial-Mesenchymal Transition; Female; H | 2018 |
Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis.
Topics: Animals; Apoptosis; Carcinoma; Cell Line, Tumor; Claudins; Dasatinib; Female; Gene Expression Regula | 2015 |